Request Free Sample
×
France Morphine Market
ID: MRFR/HC/49741-HCR
200 Pages
February 2026
France Morphine Market Research Report: By Dosage Form (Injection, Oral, Other Dosage Forms), By Application (Pain Management, Diarrhea Suppressant, Cold & Cough Suppressant, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) andBy End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)- Forecast to 2035
Industry Developments
The France Morphine Market has experienced notable developments in recent months, particularly concerning its regulatory landscape and market dynamics. In June 2023, the French government underscored its commitment to enhancing access to pain management therapies, including morphine, while maintaining stringent controls to prevent misuse. Companies such as UCB and Merck continue to invest in Research and Development to innovate formulations that improve efficacy and safety. In the realm of mergers and acquisitions, no recent significant transactions involving major players like Johnson and Johnson, Baxter, or AbbVie have been reported through established news platforms. However, past years saw various partnerships aimed at developing pain relief solutions tailored to patient needs. The market is witnessing growth, with an increased valuation attributed to the rising prevalence of chronic pain conditions in France. Figures as of September 2022 indicated a market uptick owing to heightened awareness of pain management therapies among healthcare professionals. Additionally, the collaboration between pharmaceutical firms and healthcare stakeholders is expected to pave the way for improved morphine distribution frameworks, potentially leading to broader patient access across French healthcare settings.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 810.0(USD Million) |
| MARKET SIZE 2024 | 863.5(USD Million) |
| MARKET SIZE 2035 | 1520.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.275% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | UCB, Johnson & Johnson, Baxter, Merck, Mundipharma, Novartis, AbbVie, Sandoz, Roche, Sanofi, Teva, Pfizer, AOP Orphan Pharmaceuticals, AstraZeneca, Gedeon Richter |
| SEGMENTS COVERED | Dosage Form, Application, Distribution Channel, End User |
| KEY MARKET OPPORTUNITIES | Rising cancer prevalence, Expanding palliative care services, Increasing opioid prescriptions, Innovative delivery methods, Regulatory support for pain management |
| KEY MARKET DYNAMICS | Rising cancer prevalence, Increasing pain management awareness, Regulatory changes impacting supply, Growth in palliative care services, Competition from alternative analgesics |
| COUNTRIES COVERED | France |
Leave a Comment
FAQs
What is the expected market size of the France Morphine Market in 2024?
The France Morphine Market is expected to be valued at 863.5 million USD in 2024.
What will be the projected market size of the France Morphine Market by 2035?
By 2035, the France Morphine Market is expected to grow to a value of 1520.0 million USD.
What is the expected CAGR for the France Morphine Market from 2025 to 2035?
The expected compound annual growth rate (CAGR) for the France Morphine Market is 5.275% from 2025 to 2035.
Which segment of the France Morphine Market holds the largest market share?
The Injection segment of the France Morphine Market holds the largest share, valued at 400.0 million USD in 2024.
What will the market value of the Oral dosage form be in 2035?
The Oral dosage form of the France Morphine Market is projected to reach a value of 600.0 million USD by 2035.
Who are the key players in the France Morphine Market?
Key players in the France Morphine Market include UCB, Johnson & Johnson, Baxter, and Merck among others.
How much is the Other Dosage Forms segment valued at in 2024?
The Other Dosage Forms segment of the France Morphine Market is valued at 163.5 million USD in 2024.
What are some emerging trends in the France Morphine Market?
Emerging trends include advancements in dosage forms and increasing demand for pain management treatments in the France Morphine Market.
What are the growth drivers for the France Morphine Market?
Growth drivers for the France Morphine Market include an increasing geriatric population and rising incidences of chronic pain.
What challenges may impact the France Morphine Market growth?
Challenges impacting growth may include regulatory hurdles and potential public perception issues regarding opioid use.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense